Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma

骨肉瘤 免疫染色 组织微阵列 染色 病理 免疫组织化学 生物 转移 癌症 医学 癌症研究 遗传学
作者
Juncheng Cui,Dylan C. Dean,Ran Wei,Francis J. Hornicek,David Ulmert,Zhenfeng Duan
出处
期刊:Journal of Orthopaedic Research [Wiley]
卷期号:38 (11): 2362-2372 被引量:28
标识
DOI:10.1002/jor.24848
摘要

Leucine-rich repeat containing 15 (LRRC15) is a member of the leucine-rich repeat superfamily that is overexpressed in various cancers and associated with higher tumor grade and aggression. Despite its known tumorigenicity, its roles within osteosarcoma are unknown, prompting us to evaluate its expression and clinical significance within this rare yet aggressive cancer. Western blots showed differential expression of LRRC15 in the osteosarcoma cell lines MNNG/HOS, KHOS, 143B, MG63, Saos-2, and U2OS. We additionally validated this positive expression, as well as sublocalization to the cell membrane, with immunofluorescence. A tissue microarray constructed from 69 osteosarcoma patient tissues was immunohistochemically stained for LRRC15 expression, stratified, and used for clinicopathological analysis. Publicly available databases on LRRC15 expression, including RNA sequencing data from the Therapeutically Applicable Research to Generate Effective Treatments on Osteosarcoma (TARGET-OS) and the Gene Expression database of Normal and Tumor tissues 2 (GENT2) were also analyzed. We found 63 of the 69 (91.3%) patient tissues exhibited some degree of LRRC15 immunostaining, including no staining (6 of 69, 8.7%), 1+ staining (12 of 69, 17.4%), 2+ staining (25 of 69, 36.2%), and 3+ staining (26 of 69, 37.7%). The patients with osteosarcomas having elevated LRRC15 expression demonstrated comparatively increased metastasis, chemoresistance, and shorter 5-year survival rates. Our analysis of the TARGET-OS and GENT2 databases also showed increased LRRC15 gene expression in osteosarcoma. Taken together, our study supports LRRC15 as a prognostic biomarker and emerging therapeutic target in osteosarcoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
moyv发布了新的文献求助10
刚刚
笨笨的傲白完成签到,获得积分20
刚刚
1秒前
黑米粥发布了新的文献求助200
1秒前
2秒前
科研通AI6.4的应助被声声采纳,获得10
4秒前
4秒前
cfy完成签到,获得积分10
5秒前
噗喵喵发布了新的文献求助10
5秒前
赘婿的应助被沉沉叠叠采纳,获得10
5秒前
fujing发布了新的文献求助10
6秒前
kitty发布了新的文献求助10
6秒前
Y希完成签到 ,获得积分10
6秒前
Songzhu发布了新的文献求助10
6秒前
乐乐宝完成签到,获得积分10
6秒前
7秒前
共享精神的应助被酷酷的海云采纳,获得10
7秒前
8秒前
小猪乔治完成签到,获得积分10
8秒前
孙崇翔完成签到,获得积分10
9秒前
英姑的应助被美满的灵安采纳,获得10
10秒前
10秒前
12秒前
隐形曼青的应助被小缓采纳,获得10
12秒前
12秒前
星辰大海的应助被xujiahao采纳,获得10
12秒前
佚名发布了新的文献求助10
13秒前
14秒前
青雾雨的应助被水天需采纳,获得10
15秒前
15秒前
大模型的应助被科研通管家采纳,获得10
16秒前
黑米粥发布了新的文献求助200
16秒前
Orange的应助被科研通管家采纳,获得10
16秒前
隐形曼青的应助被科研通管家采纳,获得10
16秒前
所所的应助被科研通管家采纳,获得10
16秒前
桐桐的应助被科研通管家采纳,获得10
16秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
16秒前
小马甲的应助被科研通管家采纳,获得10
17秒前
在水一方的应助被科研通管家采纳,获得10
17秒前
丘比特的应助被科研通管家采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184008
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829656
捐赠科研通 7781040
什么是DOI,文献DOI怎么找? 3434187
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480658